Welcome to PsychU!

Webinars

PsychU webinars offer a platform for experts in the field of mental health to share their knowledge and experiences through live presentations and answer questions from the audience. After the live event, all webinars are available on-demand for PsychU community members to watch (or re-watch) and download the slide deck presentation.

  1. Events
  2. Webinar

Events Search and Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Event Views Navigation

Today

The Use Of Digital Tools For Serious Mental Illness & Substance Use Disorder

Webinar January 26, 2022 12:00pm to 1:00pm EST
The use of digital tools for the treatment of patients with mental illness is a dynamic and rapidly growing area of interest. In this webinar, Dr. Michael E. Thase, MD and Dr. Craig Chepke, MD will discuss unmet treatment needs in serious mental illness and substance use disorder. They will...

The Impact Of Systemic Racism On Black Americans’ Wellness

Webinar February 23, 2022 12:00pm to 1:00pm EST
Over the past 2 years, during the age of COVID-19 pandemic, the spotlight has been on inequity and disadvantages faced by many Black Americans who try to access healthcare services in the United States. In celebrating Black History Month, PsychU & NephU have invited Dr. Napoleon Higgins to discuss the...

Call To Action: The Need For Stigma Awareness In Healthcare Professional Education

Webinar March 09, 2022 12:00pm to 1:00pm EST
Recognizing the need for awareness of mental health stigma in healthcare professional education programs can be challenging. In this webinar, our panelists from medical, pharmacy, and psychology academic settings will discuss how mental health is addressed in their respective curricula, highlight opportunities to address self-stigma, and share resources available to...

Having The Snooze Blues? State Of The Science On Sleep In Mood Disorders

Webinar March 23, 2022 12:00pm to 1:00pm EDT
Sleep disturbance is a predominant symptom associated with depression, impacting ~75% of those diagnosed with depression. Insomnia, hypersomnia, and obstructive sleep apnea are all highly prevalent among those with depression.1 An estimated 40% of individuals among the general and healthcare populations have reported sleep problems because of the COVID pandemic,...

Impact of Adherence on Patients with BP I Disorder

Webinar March 31, 2022 12:00pm to 1:00pm EDT
Treatment non-adherence is a dilemma in bipolar disorder and is one of the leading challenges in providing effective treatments for people diagnosed with BP I disorder. During our discussion today, Dr. Sajatovic and Dr. Goldberg will discuss and define some of these challenges and provide the latest information on treatment-related...

The Depression Dance: Navigating Unresolved Symptoms & Other Treatment Complexities

Webinar April 27, 2022 12:00pm to 1:00pm EDT
Residual symptoms of depression are very common in patients who are classified as being in response or even remission. In individuals with residual symptoms, we see an increased risk of functional & interpersonal impairments, as well as a significantly increased risk for recurrence of depression. For many patients, residual symptoms...

Re-Imagining The Dopamine Hypothesis Of Schizophrenia: How Can We Find A Balance?

Webinar May 24, 2022 12:00pm to 1:00pm EDT
The dopamine hypothesis of schizophrenia has been foundational in elucidating the benefit of dopamine-blocking actions of antipsychotic medications over the past 60 years. Although blocking the D2 receptors may lead to positive symptom-alleviation in schizophrenia, doing so may come at a great cost to the overall well-being of individuals with...

Recognizing The Inner Voice: Breaking The LGBTQIA+ Conversation Barrier

Webinar June 01, 2022 12:00pm to 1:00pm EDT
The month of June is Pride Month and throughout the world the LGBTQIA+ communities come together to celebrate sexual and gender diversity, and to raise awareness of the ongoing pursuit for equality. NephU and PsychU will be joining the community awareness efforts. During this webinar, our speakers begin by sharing...

Managing Partial Response: Augmentation Strategies In MDD

Webinar June 27, 2022 12:00pm to 1:00pm EDT
Persistent residual symptoms (e.g., sleep disturbances, cognitive symptoms) have known interference on quality of life and functioning of individuals with major depressive disorder (MDD) who respond to or remit from antidepressant treatment.1 Understanding the inherent challenges in symptom recognition and subsequent treatment, clinicians are tasked with finding optimal symptom relief...

Digital Health Tools: Combating Stigma & Healthcare Disparities

Webinar July 28, 2022 12:00pm to 1:00pm EDT
Dr. Velligan and Dr. Pederson will share their expertise in the areas of digital tools, stigma, and healthcare disparities. Together, they will provide an overview of stigma and healthcare disparities in mental health treatment, and then discuss digital tools used in the treatment of mental illness. Finally, we will explore...

A Conversation With An Expert In Agitation In Alzheimer’s Dementia, A Person With Lived Experience, & A Care Partner

Webinar August 02, 2022 12:00pm to 1:00pm EDT
Alzheimer’s dementia is highly prevalent, under-diagnosed, and predicted to increase significantly in the coming decades due to an aging population. Unfortunately, a large proportion of individuals with Alzheimer’s disease (AD) also experience neuropsychiatric symptoms, such as agitation, depression, apathy, and hallucinations. In this webinar, our panelist will be reviewing the...

Panel Discussion On The Role Of Psychotherapy, Cognitive Training, & Digital Platforms For Treatment Of Major Depressive Disorder

Webinar August 30, 2022 12:00pm to 1:00pm EDT
Psychotherapy, particularly cognitive behavioral therapy, is a widely accepted and effective treatment approach for major depressive disorder.1 Cognitive training represents a promising and novel therapeutic intervention to address cognitive and affective symptoms of depression.2 Individual and systematic barriers may limit initiation and adherence to psychological interventions.3 Digital platforms may be...

988: What’s The Scoop? A Discussion With Experts In Suicide Prevention & Mental Health

Webinar September 13, 2022 12:00pm to 1:00pm EDT
988, the three-digit dialing code developed and designed as a suicide and crisis lifeline, went live on July 16, 2022. Since Congress designated 988 in 2020, there has been a lot of excitement, confusion, and buzz around exactly what this new number means for individuals in crisis, healthcare providers, and...

Defining, Evaluating, & Implementing Digital Health Tools

Webinar September 21, 2022 12:00pm to 1:00pm EDT
In this webinar, Dr. Vasan and Dr. Behrens will share their expertise in the areas of digital tools. Together, they will provide definitions of digital health tools and discuss how those tools may help address some unmet needs. They will also provide best practices for digital tool design and clinical...

Quality Matters: An Update From NCQA On Behavioral Health Measurement Trends

Webinar September 27, 2022 12:00pm to 1:00pm EDT
The National Committee for Quality Assurance (NCQA) collects information on the performance of health care service delivery from health plans covering more than 191 million people using its proprietary Healthcare Effectiveness Data and Information Set, or HEDIS. One of health care’s most widely used performance improvement tools, HEDIS consists of...

Pathophysiology Of Agitation Associated With Alzheimer’s Dementia: The Potential Role Of The Norepinephrine, Serotonin, & Dopamine (NSD) Neurotransmitter Systems

Webinar October 26, 2022 12:00pm to 1:00pm EDT
Tau pathology and neurodegeneration in key prefrontal and subcortical brain regions may increase the risk of developing agitation in Alzheimer’s dementia.1 Specifically, agitation in Alzheimer’s dementia may reflect an imbalance between top-down executive control (i.e., hypoactivity in prefrontal regions) and bottom-up emotional drive (i.e., hyperactivity in subcortical regions including the...

Early Intervention in Bipolar Disorder

Webinar November 02, 2022 12:00pm to 1:00pm EDT
During this webinar, Dr. Goldberg and Dr. Tohen will discuss the importance of early intervention in patients diagnosed with bipolar disorder. Together they will share their clinical experience and discuss the implications of early versus delayed intervention and identify and explore potential treatment options in bipolar disorder. Objectives: Describe the...

Schizophrenia Treatment Goals & Shared Decision Making: A Practice-Based Learning Webinar

Webinar November 09, 2022 12:00pm to 1:00pm EST
Join Dr. Correll and Dr. Schooler for a discussion on how to engage patients in their own treatment decisions, help them define their treatment goals, and address treatment barriers that are often associated with schizophrenia. Together, they will lead an engaging practice-based learning session designed to both teach shared decision-making...

Professional Mental Wellness: The Role Of Organizational & Occupational Health

Webinar November 15, 2022 12:00pm to 1:00pm EST
Organizational and occupational health refers to any workplace health promotion activity or organizational policy designed to support healthy behavior in the workplace and to improve health outcomes.1 Usually, this includes physical health programs such as smoking cessation, health screenings, exercise initiatives, and vaccination clinics; however, many organizations have also been...

The Value Of Digital Therapeutics

Webinar December 06, 2022 12:00pm to 1:00pm EST
Description: Digital therapeutics, a subset of digital health, are evidence-based, clinically validated software that combine health and technology to prevent, treat, or manage a medical condition. In this discussion, Dr. Madhukar Trivedi and Dr. Albert Mei will introduce the role of digital therapeutics in the current mental health landscape, describe...

Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia

Webinar December 13, 2022 12:00pm to 1:00pm EST
Trace amines and trace amine-associated receptors (TAAR) are found throughout the brain and peripheral tissues and have modulating effects on neurotransmitters including dopamine, glutamate, and serotonin.1,2 The speaker(s) will discuss what are some of the potential effects of TAAR1 on neurotransmitter signaling related to schizophrenia and some of the preclinical...

Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia

Webinar January 11, 2023 12:00pm to 1:00pm EST
Agitation associated with Alzheimer’s Dementia (AAD) lead to worsening outcomes in an already devastating disease. A patient-centered focus is recommended for a comprehensive treatment plan. In this webinar, the speakers will review the burden of AAD, then discuss current treatment recommendations and unmet needs. Objectives: Review the economic and caregiver...

Pharmacokinetics, Plasma Concentrations & (Their) Clinical Relevance

Webinar January 26, 2023 12:00pm to 1:00pm EST
Pharmacokinetics refers to the study of how drugs are processed by the body. These processes play an important role in mental health treatments, and can vary due to several factors, ultimately impacting treatment of mental health. In this webinar, we will first provide an overview of pharmacokinetics and pharmacodynamics. Then,...

On-Demand Webinars

REQUEST A PRESENTATION

Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.

Top Requested Presentations

Social Determinants Of Health

Agitation Associated With Alzheimer’s Dementia Disease State Education

The Importance Of Population Health: A Mental Health Perspective

Learning Tracks